HUTCHMED (China) Statistics
HUTCHMED (China) (H7T2) Stock Statistics & Valuation Metrics
Total Valuation
HUTCHMED (China) has a market cap or net worth of EUR 2.42B. The enterprise value is EUR 4.72B.
- Market Cap
- EUR 2.42B
- Enterprise Value
- EUR 4.72B
Share Statistics
HUTCHMED (China) has 872,335,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 872,335,140
- Owned by Insiders
- 0.72%
- Owned by Institutions
- 5.86%
Financial Efficiency
HUTCHMED (China) ’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is -2.35%.
- Return on Equity (ROE)
- 0.37
- Return on Assets (ROA)
- 0.26
- Return on Invested Capital (ROIC)
- -2.35%
- Return on Capital Employed (ROCE)
- -0.03
- Revenue Per Employee
- 305.41K
- Profits Per Employee
- 254.40K
- Employee Count
- 1,796
- Asset Turnover
- 0.31
- Inventory Turnover
- 11.79
Valuation Ratios
The current PE Ratio of HUTCHMED (China) is 167.30. HUTCHMED (China) ’s PEG ratio is -1.73.
- PE Ratio
- 167.30
- PS Ratio
- 4.90
- PB Ratio
- 2.13
- Price to FCF
- 270.35
- Price to Operating Cash Flow
- 130.98
- PEG Ratio
- -1.73
Income Statement
In the last 12 months, HUTCHMED (China) had revenue of 548.51M and earned 456.91M in profits. Earnings per share was 0.52.
- Revenue
- 548.51M
- Gross Profit
- 63.87M
- Operating Income
- -39.16M
- Pretax Income
- 521.34M
- Net Income
- 456.91M
- EBITDA
- -25.85M
- Earnings Per Share (EPS)
- 0.52
Cash Flow
In the last 12 months, operating cash flow was 20.46M and capital expenditures -10.51M, giving a free cash flow of 9.95M billion.
- Operating Cash Flow
- 20.46M
- Free Cash Flow
- 9.95M
- Free Cash Flow per Share
- 0.01
Dividends & Yields
HUTCHMED (China) pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.37%
- Earnings Yield
- 0.67%
Stock Price Statistics
- Beta
- 0.21
- 52-Week Price Change
- -7.91%
- 50-Day Moving Average
- 2.30
- 200-Day Moving Average
- 2.14
- Relative Strength Index (RSI)
- 63.90
- Average Volume (3m)
- ―
Important Dates
HUTCHMED (China) upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jul 30, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
HUTCHMED (China) as a current ratio of 4.96, with Debt / Equity ratio of 7.91%
- Current Ratio
- 4.96
- Quick Ratio
- 4.83
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -1.03
- Interest Coverage Ratio
- -13.67
Taxes
In the past 12 months, HUTCHMED (China) has paid 63.61M in taxes.
- Income Tax
- 63.61M
- Effective Tax Rate
- 0.12
Enterprise Valuation
HUTCHMED (China) EV to EBITDA ratio is -130.53, with an EV/FCF ratio of 269.16.
- EV to Sales
- 4.88
- EV to EBITDA
- -130.53
- EV to Free Cash Flow
- 269.16
- EV to Operating Cash Flow
- 130.89
Balance Sheet
HUTCHMED (China) has EUR 1.38B in cash and marketable securities with EUR 94.51M in debt, giving a net cash position of EUR 1.28B billion.
- Cash & Marketable Securities
- EUR 1.38B
- Total Debt
- EUR 94.51M
- Net Cash
- EUR 1.28B
- Net Cash Per Share
- EUR 1.47
- Tangible Book Value Per Share
- EUR 1.47
Margins
Gross margin is 0.20%, with operating margin of -6.33%, and net profit margin of 3.26%.
- Gross Margin
- 0.20%
- Operating Margin
- -6.33%
- Pretax Margin
- 3.66%
- Net Profit Margin
- 3.26%
- EBITDA Margin
- -3.74%
- EBIT Margin
- -6.33%
Analyst Forecast
The average price target for HUTCHMED (China) is EUR 3.53, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 3.53
- Price Target Upside
- 37.75% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 9
- Revenue Growth Forecast
- -15.02%
- EPS Growth Forecast
- -96.45%
Scores
- Smart Score
- 9
- AI Score
- ―
